Better Lupus -Analysis: How to execute the exam and results analysis

LE -SEL test sponsored in the lupus erythematosus examine the presence of special cells that distinguish the systemic lupus erythematosus -SLE), this disease is an autonomous disease (auto -immune disease) is characterized by damage to different tissues, such as: kidneys, skin, joints and nerve devices. This test is not sensitive and not -qualitative, as 25% of those with lupus have no lupus cells (lupus erythematosus -cell -lies), and we can find these cells in many pathological conditions, so this test is almost not done today and more qualitative methods are used today, such as: antibodies against DNA. Category that is at risk or that has symptoms of lupus erythematosus, or is suspected of this disease. How to conduct the examination of this test, it is confirmed that the presence of antibodies for nuclear proteins, where a blood sample of the patient is taken and then mixed with special nuclear proteins treated in the laboratory. In the event that the blood of the patient has antibodies against these proteins, they are exposed to damage, and the suspected cells swallow damaged proteins that can be easily identified under a microscope. General warnings of bleeding under the skin in the blood sample taking area. During pregnancy: There are no special problems. Breastfeeding: There are no special problems. Children and babies are not special problems. Elderly: There are no special problems. Management: There are no special problems. Medicines that affect the result of the investigation. Many medications can affect the results of the investigation, which includes: Hydralazine. Procainamide. Cinidine. Phenytoin. Penicillin antibiotics. Sulfonamide. Methyldopa. Isoniazid. Sanctuary. Phenylbutazone. The pill can lead to a false positive result. Results -analysis